Tokyo Tape
Sign in
← BrightPath Biotherapeutics

Half-year report · Q2

4594.TEDINET S100UNRO
Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 43
MetricValuePeriodScopeSource row
Revenue¥56,0002024-04-01 → 2024-09-30StandaloneNet sales
Revenue¥72,0002023-04-01 → 2024-03-31StandaloneNet sales (5-year summary)
Revenue¥44,0002023-04-01 → 2023-09-30StandaloneNet sales
Operating income−¥543m2024-04-01 → 2024-09-30StandaloneOperating income
Operating income−¥551m2023-04-01 → 2023-09-30StandaloneOperating income
Ordinary income−¥538m2024-04-01 → 2024-09-30StandaloneOrdinary income
Ordinary income−¥1.2bn2023-04-01 → 2024-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥552m2023-04-01 → 2023-09-30StandaloneOrdinary income
Profit before tax−¥538m2024-04-01 → 2024-09-30StandaloneIncome before income taxes
Profit before tax−¥553m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Net income−¥539m2024-04-01 → 2024-09-30StandaloneProfit loss
Net income−¥1.2bn2023-04-01 → 2024-03-31StandaloneNet income loss (5-year summary)
Net income−¥554m2023-04-01 → 2023-09-30StandaloneProfit loss
Total assets¥1.7bnat 2024-09-30StandaloneAssets
Total assets¥1.2bnat 2024-03-31StandaloneAssets
Total assets¥1.2bnat 2023-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥462mat 2024-09-30StandaloneLiabilities
Total liabilities¥251mat 2024-03-31StandaloneLiabilities
Net assets / equity¥1.2bnat 2024-09-30StandaloneNet assets
Net assets / equity¥979mat 2024-03-31StandaloneNet assets
Net assets / equity¥1.0bnat 2023-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.5bnat 2024-09-30StandaloneCash and deposits
Cash and deposits¥1.1bnat 2024-03-31StandaloneCash and deposits
Cash & equivalents¥1.5bnat 2024-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2023-03-31dStandaloneCash and cash equivalents
Operating cash flow−¥521m2024-04-01 → 2024-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥466m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥8m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥1.0bn2024-04-01 → 2024-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥691m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-7.112024-04-01 → 2024-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-18.212023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-8.812023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio71.4%at 2024-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.7%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio85.4%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued83,791,300at 2024-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued70,741,300at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued62,891,200at 2023-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 352
ItemContextValueUnit
Interest and dividends income ope cfCurrentYTDDuration_NonConsolidatedMember-47000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration_NonConsolidatedMember24000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration_NonConsolidatedMember-24000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration_NonConsolidatedMember-64000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration_NonConsolidatedMember-4000JPY
Increase decrease in provision for retirement benefits ope cfPrior1YTDDuration_NonConsolidatedMember660000JPY
Increase decrease in provision for retirement benefits ope cfCurrentYTDDuration_NonConsolidatedMember4057000JPY
Other net ope cfPrior1YTDDuration_NonConsolidatedMember86468000JPY
Other net ope cfCurrentYTDDuration_NonConsolidatedMember9140000JPY
Subtotal ope cfPrior1YTDDuration_NonConsolidatedMember-464436000JPY
Subtotal ope cfCurrentYTDDuration_NonConsolidatedMember-524665000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration_NonConsolidatedMember9000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration_NonConsolidatedMember42000JPY
Income taxes paid ope cfPrior1YTDDuration_NonConsolidatedMember-1900000JPY
Income taxes paid ope cfCurrentYTDDuration_NonConsolidatedMember-1900000JPY
Settlement package received ope cfPrior1YTDDuration_NonConsolidatedMember－JPY
Settlement package received ope cfCurrentYTDDuration_NonConsolidatedMember5939000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration_NonConsolidatedMember-466327000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration_NonConsolidatedMember-520584000JPY
Purchase of intangible assets inv cfPrior1YTDDuration_NonConsolidatedMember-1454000JPY
Purchase of intangible assets inv cfCurrentYTDDuration_NonConsolidatedMember－JPY
Net cash provided by used in investment activitiesPrior1YTDDuration_NonConsolidatedMember-1454000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration_NonConsolidatedMember－JPY
Proceeds from issuance of bonds fin cfPrior1YTDDuration_NonConsolidatedMember－JPY
Proceeds from issuance of bonds fin cfCurrentYTDDuration_NonConsolidatedMember500000000JPY
Redemption of bonds fin cfPrior1YTDDuration_NonConsolidatedMember－JPY
Redemption of bonds fin cfCurrentYTDDuration_NonConsolidatedMember-287500000JPY
Payments for purchase of treasury subscription right to shares fin cfPrior1YTDDuration_NonConsolidatedMember－JPY
Payments for purchase of treasury subscription right to shares fin cfCurrentYTDDuration_NonConsolidatedMember-1042000JPY
Proceeds from issuance of subscription rights to shares fin cfPrior1YTDDuration_NonConsolidatedMember－JPY
Proceeds from issuance of subscription rights to shares fin cfCurrentYTDDuration_NonConsolidatedMember2580000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfPrior1YTDDuration_NonConsolidatedMember－JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYTDDuration_NonConsolidatedMember788581000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration_NonConsolidatedMember－JPY
Net cash provided by used in financing activitiesCurrentYTDDuration_NonConsolidatedMember1002619000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration_NonConsolidatedMember-467781000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember482034000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember1530969000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1057360000JPY
Cash and cash equivalentsPrior1QuarterInstant_NonConsolidatedMember1063188000JPY
Cash and cash equivalentsCurrentQuarterInstant_NonConsolidatedMember1539394000JPY
Research and development expenses sgaPrior1YTDDuration_NonConsolidatedMember363891000JPY
Research and development expenses sgaCurrentYTDDuration_NonConsolidatedMember399969000JPY
Retirement benefit expenses sgaPrior1YTDDuration_NonConsolidatedMember－JPY
Retirement benefit expenses sgaCurrentYTDDuration_NonConsolidatedMember490000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-11-08
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第22期中(自 2024年４月１日 至 2024年９月30日)

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2024-03-31pass
balance sheet identitynon_consolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2024-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2024-04-01/2024-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2024-09-30pass